Title : Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients.

Pub. Date : 2021 Mar 15

PMID : 32426829






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 At 12 months, steroid-free clinical and biochemical remission on the same anti-TNF occurred in 53.9% of the IM group vs 26.8% in the No-IM group (P = 0.025). Steroids tumor necrosis factor Homo sapiens
2 CONCLUSIONS: Pediatric patients with inflammatory bowel disease on anti-TNF monotherapy who started an IM for significant ADA levels exhibited longer anti-TNF durability and a higher likelihood of steroid-free clinical and biochemical remission on the same anti-TNF. Steroids tumor necrosis factor Homo sapiens